Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an update.
Resmed Inc has filed a Form 144 notice indicating the proposed sale of securities under Rule 144 of the Securities Act of 1933. The filing details the sale of 9,745 common shares with an aggregate market value of approximately $2.33 million, to be executed on the NYSE. The transaction involves shares acquired through options granted in previous years, with the sale potentially impacting the company’s stock liquidity and market perception.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep apnea and other respiratory conditions. The company is known for its innovative solutions in sleep and respiratory care, catering to a global market.
YTD Price Performance: -0.68%
Average Trading Volume: 1,062,192
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.39B
Learn more about RMD stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com